
The world is facing a growing threat from viruses and bacteria, including new pathogens, drug-resistant strains and microbes that can survive on surfaces for days or even weeks. Traditional antimicrobial solutions often rely on synthetic chemicals or metals, which can raise concerns about health, safety and environmental impact.
A groundbreaking study published in the International Journal of Biological Macromolecules has confirmed that CH-Bioforce’s sustainably produced, aqueous-based lignins have significant antimicrobial activity against both viruses and bacteria.
Produced from birch chips, wheat straw and oat husks using CH-Bioforce’s patented BIOFORSENSE® fractionation technology, these lignins achieve up to 99% purity with minimal carbohydrate content, which is an important factor in ensuring consistent bioactivity.
In collaboration with the University of Jyväskylä and Spinnova, the research tested the lignins against:
Viruses: Non-enveloped enteroviruses (CVA9 and EV-A71) and enveloped coronaviruses (HCoV-OC43 and SARS-CoV-2).
Bacteria: Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli.
The results point to a new, sustainable class of bio-based antimicrobials that can replace or complement synthetic chemicals and metals, which often have environmental or safety drawbacks. Potential applications include:
By harnessing the natural protective chemistry of lignin, CH-Bioforce is helping pave the way toward a cleaner, safer, and more sustainable future.
Reference:
Liu, J., Haapakoski, M., Sundberg, L-R., Vähäsalo, L., Vento, P., Pöysti, M., & Marjomäki, V. (2025). Aqueous-based lignin extractions from birch, wheat, and oat exhibit broad antimicrobial activities. International Journal of Biological Macromolecules, 319, 145736.
https://doi.org/10.1016/j.ijbiomac.2025.145736
CH-Bioforce Oy is a Finnish start-up founded in 2016. The company’s innovative fractionation technology dates back to 2011, when inventors Lari Vähäsalo, Nicholas Lax and Sebastian von Schoultz made their first findings. Today, the company forms part of the Chemec group, which operates in the chemical industry. CH-Bioforce currently employs ten members of staff. Our R&D and pilot plant is located in Raisio, Finland.